Revolver
Revolver Therapeutics is at the forefront of a revolution in cancer treatment. By targeting transcription factors with innovative peptide-based therapeutics, the company is opening a new frontier in addressing previously untreatable cancers. With UKI2S backing and a clear focus on delivering impactful solutions, Revolver is poised to make a lasting difference in the fight against childhood gliomas and beyond.